A phase I study of IMP321 and gemcitabine as the front-line therapy in patients with advanced pancreatic adenocarcinoma
| Image |  |
|---|---|
| Description | scientific article published on 4 August 2012 |
| Author/s |
author: Jonathan B. Mitchem |
| Publication date | August 4, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |